Evidence-Based Oncology
Issue:
December
Volume:
18
Number:
SP5
Evidence-Based Oncology
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Marj P. Zimmerman, MS, BSPharm, RPh; and Stanton R. Mehr
Marj P. Zimmerman, MS, BSPharm, RPh; and Stanton R. Mehr
Ben Leach
Maurie Markman, MD
Lisa A. Fox
Ira M. Klein, MD, MBA, FACP
Tomorrow’s Multiple Myeloma Treatments and the Value of Subtype Analysis
Interview with David Siegel, MD, chief of the Division of Multiple Myeloma, John Theurer Cancer Center
Kim Farina, PhD
Kurt Ullman
Jill M. Comeau, PharmD, BCOP; Michael Marlan Mohundro, PharmD; and Brice Labruzzo Mohundro, PharmD
Stanton R. Mehr
E. David Crawford, MD; and Kyle O. Rove, MD